A patent application was filed by ImStar Therapeutics from Vancouver and by Université Laval in the name of inventors Jean-Pierre Julien, from Université Laval, and Anthony Shaw and Agnes Chan, for the use of molecules derived from compounds naturally occuring in indian gingseng for the treatment of Amyotrophic Lateral Sclerosis (ALS) and of four other neurodegenerative diseases.
These promising molecules offer new hope to people suffering from ALS, also known as Lou Gehrig's disease, a neurodegenerative disease causing muscle paralysis, and eventually, death. There are currently, no cures or effective treatments for this devastating disease.
Learn more about the molecules tested by professor Julien and his colleagues in le Fil de l'Université Laval:
Inspirés par la nature -
